Diabetic neuropathy models: Are they relevant?

Drug Discovery Today: Disease Models

Volumn 3, Issue 4, 2006, Pages 397-402

  Apfel, Stuart C ^a  

^a Parallax Clinical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GALACTOSE; GLUCOSE; INSULIN; STREPTOZOCIN;

COMPUTER MODEL; DIABETIC NEUROPATHY; DISEASE MODEL; GENETIC MODEL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAIN THRESHOLD; PATHOGENESIS; POLYNEUROPATHY; REVIEW; STRAIN DIFFERENCE; TISSUE CULTURE;

EID: 33846613655     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.014     Document Type: Review

References (35)

1. Argoff C.E., et al. Diabetic peripheral neuropathic pain: clinical and quality of life issues. Mayo Clinic Proceedings 81 Suppl. 4 (2006) S3-S11
2. Boulton A.J., et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diab. Care 28 (2005) 956-962
3. Vinik A.I., et al. Diabetic neuropathies. Med. Clin. North Am. 88 (2004) 947-999
4. Vincent A.M., and Feldman E.L. New insights into the mechanisms of diabetic neuropathy. Rev. Endocr. Metab. Disord. 5 (2004) 227-236
5. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288 (2006) 2579-2588
6. Sima A.A.F. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?. Curr. Opin. Investig. Drugs 7 (2006) 324-337
7. Burnstock G., et al. Reversal of nerve damage in streptozotocin-diabetic rats by acute application of insulin in vitro. Clin. Sci. 75 (1988) 629-635
8. Hall K.E., et al. Impaired inhibitory G-protein contributes to increased calcium currents in rats with diabetic neuropathy. J. Neurophysiol. 86 (2001) 760-770
9. Matsuka Y., and Spigelman I. Hyperosmolar solutions selectively block action potentials in rat myelinated sensory fibers: Implications for diabetic neuropathy. J. Neurophysiol. 91 (2004) 48-56
10. Honma H., et al. Acute glucose deprivation leads to apoptosis in a cell model of acute diabetic neuropathy. J. Peripher. Nerv. Syst. 8 (2003) 65-74
11. Honma H., et al. Hypoxia-induced apoptosis of dorsal root ganglion neurons is associated with DNA damage recognition and cell cycle disruption in rats. Neurosci. Lett. 354 (2004) 95-98
12. Terashima T., et al. The fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy. Proc. Natl. Acad. Sci. U S A 102 (2005) 12525-12530
13. Rees D.A., and Alcolado J.C. Animal models of diabetes mellitus. Diab. Med. 22 (2005) 359-370
14. Federiuk I.F., et al. Induction of Type 1 diabetes mellitus in laboratory rats by use of alloxan: Route of administration, pitfalls, and insulin treatment. Comp. Med. 54 (2004) 252-257
15. Mizisin A.P., et al. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes 53 (2004) 1807-1812
16. Kumar S.A., et al. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Neurol. Res. 27 (2005) 60-66
17. Hasegawa T., et al. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in stretozotocin-induced diabetic rats. Exp. Neurol. 199 (2006) 274-280
18. Stewart M.A., et al. Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosemia. J. Neurochem. 14 (1967) 1057-1066
19. Kennedy J.M., and Zochodne D.W. Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?. Diabetes 54 (2005) 830-837
20. Calcutt N.A., et al. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 41 (2004) 718-724
21. Moore S.A., et al. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. J. Neurol. Sci. 48 (1980) 133-152
22. Fox A., et al. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (1999) 307-316
23. Hill R.E., and Williams P.E. Perineurial cell basement membrane thickening and myelinated nerve fiber loss in diabetic and nondiabetic nerve. J. Neurol. Sci. 217 (2004) 157-163
24. Walker D., et al. Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozocin diabetic rat. J. Anatom. 195 (1999) 419-427
25. Wright R.A., and Nukada H. Sciatic nerve morphology and morphometry in mature rats with streptozocin-induced diabetes. Acta Neuropathol. (Berlin) 88 (1994) 571-578
26. Sharma A.K., et al. Influence of streptozotocin-induced diabetes on myelinated nerve fibre maturation and on body growth in the rat. Acta Neuropathol. (Berlin) 53 (1981) 257-265
27. Thomas P.K., et al. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. Acta Neuropathol. (Berlin) 79 (1990) 375-386
28. Zemp C., et al. Morphological and morphometric study of peripheral nerves from rats with streptozocin-induced diabetes mellitus. Acta Neuropathol. (Berlin) 53 (1981) 99-106
29. Rossini A.A. From beast to bedside: a commentary. Diabetologia 47 (2004) 1647-1649
30. Medori R., et al. Experimental diabetic neuropathy: Similar changes of slow axonal transport and axonal size in different animal models. J. Neurosci. 8 (1988) 1814-1821
31. Sima A.A.F., et al. A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats. Diabetologia 43 (2000) 786-793
32. Sima A.A.F., et al. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 44 (2001) 889-897
33. Kamiya H., et al. C-peptide prevents nociceptive sensory neuropathy in Type 1 diabetes. Ann. Neurol. 56 (2004) 827-835
34. Murakawa Y., et al. Impaired glucose tolerance and insulinopenia in the GK rat causes peripheral neuropathy. Diab. Metab. Res. Rev. 18 (2002) 473-483
35. Oltman C.L., et al. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am. J. Physiol.-Endocrinol. Metabol. 289 (2005) E113-E122